Please Wait...

Barbara Clendenen

Main profile

Barbara Clendenen, MBA
Barbara Clendenen, MBA
Director, Business Development, Drug Safety and Regulatory

Barbara Clendenen, MBA, designs Pharmacovigilance and Regulatory solutions that increase compliance and reduce risk for life science organizations. She has over 20 years of experience blending both science and business expertise to assist pharmaceutical, biotech, medical device, and CRO clients in meeting research and post marketing goals. She began her career as a research scientist in Immunology and Oncology.  Since 1998, she has held pivotal roles in business development and sales management within the scientific and clinical research industry for Becton Dickinson, Fisher Scientific, and Bio-Rad. Prior to joining Bioclinica in 2015, she led the Business Development Team at Quorum Review IRB, developed the organization's entry into the hospital and AMC market, and participated in CIRB (Consortium of Independent Review Boards). Barbara graduated from University of Washington with a Bachelor's degree in Microbiology and from Seattle University with a Master's in Business Administration.

Blogs

The electronic common technical document (eCTD) is an interface for the pharmaceutical industry to transfer regulatory information based on the Common Technical Document (CTD) format, which is an agreed common format for applications that will be acceptable in all three ICH-Regions (US, EU & Japan) and other countries.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (2 days ago)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (2 days ago)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (3 days ago)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (1 week ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (1 week ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (1 week ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen